Pharmaceutical compliance

Health Canada Adds New Ingredients to the Prescription Drug List

Sep

0 Comments

DINsartesunate, benzoyl peroxide, canadian regulations, crovalimab, health canada, osilodrostat, PDL update, Pharmaceutical compliance, Prescription Drug List, prescription drugs, quizartinib, Regulatory Affairs

Health Canada Adds New Ingredients to the Prescription Drug List

Health Canada has announced updates to the Prescription Drug List (PDL) that affect both human and veterinary drugs. This amendment introduces four new medicinal ingredients that now require a prescription and revises the conditions under which benzoyl peroxide is considered prescription-only for human use. These changes are effective immediately as…

Reminder: We’re Here to Support Your U.S. Regulatory Needs

Mar

0 Comments

Uncategorizeddietary supplement, dietary supplements, FDA, Food Labeling, food labelling, Food Packaging, NDA Notifications, Packaging Compliance, Pharmaceutical compliance, U.S food labelling requirements, U.S. food labels, U.S. Regulatory Services

Reminder: We’re Here to Support Your U.S. Regulatory Needs

Despite sharing a border, Canada and the U.S. have completely separate (and quite different!) regulations for products like foods and dietary supplements. And while you might know us for our Canadian services thanks to our robust client base, we want to remind you that SNI is here to support your…